Table 1 Baseline demographic characteristics of patients with IPF with a disease severity of stage I according to the JRS severity system
From: Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
Variable | Mean ± SD or number | Range |
|---|---|---|
Age, years | 71.5 ± 7.0 | 43–86 |
Sex, male/female | 148/31 | |
BMI, kg/m2 | 21.6 ± 4.3 | 14.0–32.6 |
Smoking history, N/F/C | 22/121/36 | |
GAP staging (I/II/III) | 111/58/10 | |
mMRC (0/1/2/3/4) | 28/72/62/13/3 | |
PaO2, Torr | 90.3 ± 9.1 | 62.7–127 |
%FVC, % | 81.5 ± 19.2 | 37.4–129.1 |
%DLco, % | 68.8 ± 21.3 | 23.7–143.2 |
Desaturation on 6MWT, ± | 73/106 | |
KL-6, U/ml | 938 ± 586 | 193–3374 |
SP-D, ng/ml | 271 ± 216 | 36.7–1390 |
Histological UIP diagnosis (%) | 40 (22.3%) |